Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Noy Cohen-Saban"'
Autor:
Inbal Farkash, Tali Feferman, Noy Cohen-Saban, Yahel Avraham, David Morgenstern, Grace Mayuni, Natasha Barth, Yaniv Lustig, Liron Miller, Dror S. Shouval, Asaf Biber, Ilya Kirgner, Yishai Levin, Rony Dahan
Publikováno v:
Cell Reports, Vol 37, Iss 11, Pp 110114- (2021)
Summary: Messenger RNA-based vaccines against COVID-19 induce a robust anti-SARS-CoV-2 antibody response with potent viral neutralization activity. Antibody effector functions are determined by their constant region subclasses and by their glycosylat
Externí odkaz:
https://doaj.org/article/049b5eca979b4cdfa21bb6aa2b12feff
Autor:
Victoria Indenbaum, Ravit Koren, Shiri Katz-Likvornik, Mayan Yitzchaki, Osnat Halpern, Gili Regev-Yochay, Carmit Cohen, Asaf Biber, Tali Feferman, Noy Cohen Saban, Roni Dhan, Tal Levin, Yael Gozlan, Merav Weil, Orna Mor, Michal Mandelboim, Danit Sofer, Ella Mendelson, Yaniv Lustig
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241164 (2020)
The COVID-19 pandemic and the fast global spread of the disease resulted in unprecedented decline in world trade and travel. A critical priority is, therefore, to quickly develop serological diagnostic capacity and identify individuals with past expo
Externí odkaz:
https://doaj.org/article/ee099ea138f74deea8255cb058d0f5a3
Autor:
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Ido Amit, Rony Dahan
Publikováno v:
Science Immunology. 8
FDA-approved anti–PD-L1 monoclonal antibodies (mAbs) bear the IgG1 isotype, whose scaffolds are either wild-type (e.g., avelumab) or Fc-mutated and lacking Fcγ receptor (FcγR) engagement (e.g., atezolizumab). It is unknown whether variation in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f03ecf99b8bd15282c7990b06384220
https://doi.org/10.1126/sciimmunol.add8005
https://doi.org/10.1126/sciimmunol.add8005
Autor:
Liron Miller, Natasha Barth, Inbal Farkash, Tali Feferman, Asaf Biber, Yahel Avraham, Grace Mayuni, Dror S. Shouval, Ilya Kirgner, Rony Dahan, Noy Cohen-Saban, David Morgenstern, Yaniv Lustig, Yishai Levin
Publikováno v:
Cell Reports, Vol 37, Iss 11, Pp 110114-(2021)
Cell Reports
Cell Reports
Messenger RNA-based vaccines against COVID-19 induce a robust anti-SARS-CoV-2 antibody response with potent viral neutralization activity. Antibody effector functions are determined by their constant region subclasses and by their glycosylation patte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e039920e758e34370d3d83133a62236e
http://www.sciencedirect.com/science/article/pii/S2211124721016089
http://www.sciencedirect.com/science/article/pii/S2211124721016089
Autor:
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, Assaf Weiner, Noy Cohen Saban, Tali Feferman, Ido Amit, Rony Dahan
Publikováno v:
Nature cancer. 3(3)
Therapeutic use of agonistic anti-CD40 antibodies is a potentially powerful approach for activation of the immune response to eradicate tumors. However, the translation of this approach to clinical practice has been substantially restricted due to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7817b800eba4724dbbee9c8d41356e44
https://pubmed.ncbi.nlm.nih.gov/35352058
https://pubmed.ncbi.nlm.nih.gov/35352058
Autor:
Mayan Yitzchaki, Gili Regev-Yochay, Tali Feferman, Yaniv Lustig, Asaf Biber, Michal Mandelboim, Osnat Halpern, Tal Levin, Noy Cohen Saban, Victoria Indenbaum, Orna Mor, Ravit Koren, Yael Gozlan, Roni Dhan, Ella Mendelson, Danit Sofer, Carmit Cohen, Merav Weil, Shiri Katz-Likvornik
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241164 (2020)
PLoS ONE
PLoS ONE
The COVID-19 pandemic and the fast global spread of the disease resulted in unprecedented decline in world trade and travel. A critical priority is, therefore, to quickly develop serological diagnostic capacity and identify individuals with past expo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2369225f1475eaec02dbe2d0a54572
https://doaj.org/article/ee099ea138f74deea8255cb058d0f5a3
https://doaj.org/article/ee099ea138f74deea8255cb058d0f5a3